Antigenic polypeptides

Details for Australian Patent Application No. 2007200937 (hide)

Owner University of Sheffield of Western Bank Biosynexus Inc.

Inventors McDowell, Philip; Clarke, Simon; Foster, Simon; Brummell, Kirsty

Agent Davies Collison Cave

Pub. Number AU-B-2007200937

Parent 2001274248

Filing date 2 March 2007

Wipo publication date 22 March 2007

Acceptance publication date 12 November 2009

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 39/085 (2006.01) Medicinal preparations containing antigens or antibodies - Staphylococcus

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/195 (2006.01) Peptides having more than 20 amino acids - from bacteria

C07K 14/31 (2006.01) Peptides having more than 20 amino acids

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/02 (2006.01) Mutation or genetic engineering - Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

22 March 2007 Application Open to Public Inspection

  Published as AU-B-2007200937

22 March 2007 Complete Application Filed

12 November 2009 Application Accepted

  Published as AU-B-2007200937

28 January 2010 Corrigenda

  Applications Accepted - Name Index Under the name University of Sheffield of Western Bank and Biosynexus Inc., Application No. 2007200937, under INID (71) correct co-applicant name to University of Sheffield

11 March 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007200938-Resolution of magnetic dipole ambiguity in position tracking measurements

2007200936-Device for treating a flowing fluid